Stock analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “buy” rating on the stock.
Mannatech Stock Down 3.6 %
Shares of NASDAQ MTEX opened at $11.55 on Thursday. Mannatech has a 12-month low of $6.75 and a 12-month high of $16.49. The stock has a market cap of $21.71 million, a PE ratio of -14.26 and a beta of 1.02. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. The company has a 50-day moving average of $12.07 and a 200 day moving average of $9.19.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The business had revenue of $31.73 million for the quarter.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- How to Choose Top Rated Stocks
- 3 Must-Have ETFs Set to Dominate This Quarter
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Stock Analyst Ratings and Canadian Analyst Ratings
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
